Cite Filings / CING
Feed Companies Filings Check
Sign in

CIK 0001862150 · <br>Emerging growth company

Cingulate Inc.

Sign in to watch
Ticker
CING
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
863825535
Phone
(913) 942-2300
Business address
1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
Former names
Cingulate Inc.

Securities

  • CING Common Stock Nasdaq
  • CINGW Warrants Nasdaq
Filings Insiders Search text
All 494 Financials 119 Shareholder Meetings 18 Executive Compensation 115 Insider Trading 175 Beneficial Ownership Interest 43 Business Combinations 100 Public Offerings 95 Mutual Funds and ETFs 10 Others 54
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-05-29
  3. DEF 14A Proxy Proxy Statement 2026-03-02
  4. DEF 14A Proxy Proxy Statement 2025-08-15
  5. DEF 14A Proxy Proxy Statement 2025-04-25
  6. DEF 14A Proxy Proxy Statement 2024-07-22
  7. DEF 14A Proxy Proxy Statement 2024-06-28
  8. DEF 14A Proxy Proxy Statement 2024-04-26
  9. DEF 14A Proxy Proxy Statement 2023-10-02
  10. DEF 14A Proxy Proxy Statement 2023-05-05
  11. DEF 14A Proxy Proxy Statement 2022-04-22

Page 1 of 1 · 10 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…